
GLP-1 is the first pharmaceutical disruption to impact the retail P&L as heavily as a new technology!
The highly engaging session at the National Retail Federation Big Show 2026, with the dynamic Chris Norris , Transformation Director Al-Futtaim UAE, has solidified one truth:

GROWTH SERIES 2026 | WEEK 3: THE GLP-1 BIOLOGICAL RESET
The Hard Facts: The Data Behind the GLP-1 Disruption

The scale of the GLP-1 impact is no longer theoretical. Market data from late 2025 and the early 2026 NRF sessions reveal a stark new reality:
- The Calorie Cliff: Total calorie intake among GLP-1 users drops by 20% to 30%. Walmart has already noted a “slight pullback” in the overall basket, marking the first time a biological factor has outpaced inflation in curbing grocery volume.
- The Category Shift: Consumption of carbonated soft drinks and high-sugar snacks among this demographic has plummeted by up to 50%, while demand for lean protein and hydration-focused products has surged by 18%.
- The Fashion Migration: Analysts state that 1 in 8 US adults have used these medications already (12% of population). For fashion, this represents a massive size-curve migration where the demand for XXL/XL is shrinking in favour of Medium and Large!
How Retailers Must Adapt: The MWB Blueprint
Survival in the “Lean Economy” requires a total re-engineering of the value proposition.
From Volume to Value (Grocery): In the UK and Germany, the “BOGOF” (Buy One Get One Free) model on processed goods is becoming a liability. German precision in retail is showing the way: retailers like Lidl and Rewe are pivoting toward “Functional Food” zones.

Algorithmic Size-Curve Agility (Fashion):
The move from XXL to L is a realistic three-year target for millions of consumers. Static inventory is now “dead capital.” Retailers must use AI-driven predictive modelling to shift their manufacturing ratios 12 months ahead of the curve.
The ‘Stickiness’ Solution: Coaching, Not Just Selling:
How do you keep the customer when their habits change? You become the partner in their transformation.
Fashion: Implement “Size-Swap” loyalty tiers—allowing customers to trade in garments as they lose weight, ensuring you remain their brand of choice through every stage of their “new self.”
Food: Launch “GLP-1 Companion” private labels that solve the specific side effects of the medication (e.g., muscle mass retention and hydration).
The Bailie Perspective
Strategic Trends to Watch
- The Rise of “Protein-First” Merchandising: Protein will become the new “Currency of the Aisle.”
- The End of the Impulse-Buy: AI-driven personal assistants will filter out “junk” suggestions for GLP-1 users, making the “unconscious buy” a thing of the past.
- Biometric Loyalty: Loyalty cards will evolve into “Health Passports,” where retailers provide personalised nutrition and sizing advice based on the user’s biological journey.

The “Lean Economy” is not a threat to those who move fast. It is an opportunity to shed the weight of legacy retail and build a high-velocity, high-value empire.
Is your supply chain agile enough to follow your customer through a 2-size drop in 6 months?
About the Growth Series 2026:
This series is my weekly strategic roadmap for C-Suite leaders. Recognised as a Global Top AI Leader for 2026 (#AiR), I lead MWB Advisory Ltd in providing the blueprints to operationalise the ‘Next Now’.
About the Growth Series 2026:
This series is my weekly strategic roadmap for C-Suite leaders to move from Vision to Velocity. Recognised as a Global Top AI Leader for 2026 #AiR RETHINK Retail , I lead MWB Advisory Ltd in providing the blueprints to operationalise the ‘Next Now’—from #AgenticCommerce to the #RoboticsRevolution.

